QA: BRISTOL MYERS SQUIBB CO in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000014272_2021_BRISTOL_MYERS_SQUIBB_CO.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000014272, BRISTOL MYERS SQUIBB CO

  xvar xval
0 AssetsCurrent 30,192,000,000
1 IntangibleAssetsNetIncludingGoodwill 73,790,000,000
2 PropertyPlantAndEquipmentNet 5,886,000,000
3 remainder_Assets 8,613,000,000
4 LiabilitiesCurrent 19,080,000,000
5 LiabilitiesNoncurrent 56,112,000,000
6 remainder_Liabilities 5,407,000,000
7 CostOfGoodsAndServicesSold 11,773,000,000
8 SellingGeneralAndAdministrativeExpense 7,661,000,000
9 ResearchAndDevelopmentExpense 11,143,000,000
10 remainder_Expenses 20,936,000,000
11 remainder_Revenues 42,518,000,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome -339,000,000
  yvar yval
0 Assets 118,481,000,000
1 Liabilities 80,599,000,000
2 Expenses 51,513,000,000
3 Revenues 42,518,000,000
4 StockholdersEquity 37,882,000,000
5 NetIncome -8,995,000,000
6 ComprehensiveNetIncome -9,164,500,000
7 BaseVar 146,725,000,000
8 EconomicCapitalRatio 0.563

Edgar->Model Mapping

Feature Distribution

Change over Time